Literature DB >> 27520277

The Role of Stem Cells in the Treatment of Cerebral Palsy: a Review.

Anahita Kiasatdolatabadi1, Nasrin Lotfibakhshaiesh1, Meysam Yazdankhah1,2, Somayeh Ebrahimi-Barough1, Mina Jafarabadi3, Arman Ai4, Esmaeil Sadroddiny5, Jafar Ai6.   

Abstract

Cerebral palsy (CP) is a neuromuscular disease due to injury in the infant's brain. The CP disorder causes many neurologic dysfunctions in the patient. Various treatment methods have been used for the management of CP disorder. However, there has been no absolute cure for this condition. Furthermore, some of the procedures which are currently used for relief of symptoms in CP cause discomfort or side effects in the patient. Recently, stem cell therapy has attracted a huge interest as a new therapeutic method for treatment of CP. Several investigations in animal and human with CP have demonstrated positive potential of stem cell transplantation for the treatment of CP disorder. The ultimate goal of this therapeutic method is to harness the regenerative capacity of the stem cells causing a formation of new tissues to replace the damaged tissue. During the recent years, there have been many investigations on stem cell therapy. However, there are still many unclear issues regarding this method and high effort is needed to create a technology as a perfect treatment. This review will discuss the scientific background of stem cell therapy for cerebral palsy including evidences from current clinical trials.

Entities:  

Keywords:  Cerebral palsy; Clinical trials; Stem cell; Treatment

Mesh:

Year:  2016        PMID: 27520277     DOI: 10.1007/s12035-016-0030-0

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  98 in total

1.  Review of drug treatment for Down's syndrome persons.

Authors:  J B Share
Journal:  Am J Ment Defic       Date:  1976-01

Review 2.  Synapse formation on adult-born hippocampal neurons.

Authors:  Nicolas Toni; Sebastien Sultan
Journal:  Eur J Neurosci       Date:  2011-03       Impact factor: 3.386

Review 3.  Regenerative Therapy and Immune Modulation Using Umbilical Cord Blood-Derived Cells.

Authors:  Pauline Damien; David S Allan
Journal:  Biol Blood Marrow Transplant       Date:  2015-06-14       Impact factor: 5.742

4.  Use of human umbilical cord blood mononuclear cells to prevent perinatal brain injury: a preclinical study.

Authors:  Jérémie Dalous; Julien Pansiot; Hoa Pham; Paul Chatel; Céline Nadaradja; Irene D'Agostino; Gaëlle Vottier; Leslie Schwendimann; Valérie Vanneaux; Christiane Charriaut-Marlangue; Luigi Titomanlio; Pierre Gressens; Jérôme Larghero; Olivier Baud
Journal:  Stem Cells Dev       Date:  2012-07-02       Impact factor: 3.272

5.  Covalent immobilization of stem cell factor and stromal derived factor 1α for in vitro culture of hematopoietic progenitor cells.

Authors:  Maude L Cuchiara; Kelsey L Horter; Omar A Banda; Jennifer L West
Journal:  Acta Biomater       Date:  2013-08-17       Impact factor: 8.947

Review 6.  Umbilical cord blood mesenchymal stem cells co-modified by TERT and BDNF: a novel neuroprotective therapy for neonatal hypoxic-ischemic brain damage.

Authors:  Fengyan Zhao; Yi Qu; Haiting Liu; Baowen Du; Dezhi Mu
Journal:  Int J Dev Neurosci       Date:  2014-07-03       Impact factor: 2.457

7.  Inhibitor of PI3K/Akt Signaling Pathway Small Molecule Promotes Motor Neuron Differentiation of Human Endometrial Stem Cells Cultured on Electrospun Biocomposite Polycaprolactone/Collagen Scaffolds.

Authors:  Somayeh Ebrahimi-Barough; Elham Hoveizi; Meysam Yazdankhah; Jafar Ai; Mehrdad Khakbiz; Faezeh Faghihi; Roksana Tajerian; Neda Bayat
Journal:  Mol Neurobiol       Date:  2016-03-18       Impact factor: 5.590

8.  Changes in cerebrospinal fluid nerve growth factor levels during chick embryonic development.

Authors:  Farhad Mashayekhi; Majid Azari; Lotfali Masomi Moghadam; Meysam Yazdankhah; Mohammad Naji; Zivar Salehi
Journal:  J Clin Neurosci       Date:  2009-07-05       Impact factor: 1.961

9.  Safety and tolerability of intrathecal delivery of autologous bone marrow nucleated cells in children with cerebral palsy: an open-label phase I trial.

Authors:  Consuelo Mancías-Guerra; Alma Rosa Marroquín-Escamilla; Oscar González-Llano; Laura Villarreal-Martínez; José Carlos Jaime-Pérez; Fernando García-Rodríguez; Sagrario Lisete Valdés-Burnes; Laura Nely Rodríguez-Romo; Dinorah Catalina Barrera-Morales; José Javier Sánchez-Hernández; Olga Graciela Cantú-Rodríguez; César Homero Gutiérrez-Aguirre; Andrés Gómez-De León; Guillermo Elizondo-Riojas; Rosario Salazar-Riojas; David Gómez-Almaguer
Journal:  Cytotherapy       Date:  2014-03-15       Impact factor: 5.414

Review 10.  Stem cells in clinical practice: applications and warnings.

Authors:  Daniele Lodi; Tommaso Iannitti; Beniamino Palmieri
Journal:  J Exp Clin Cancer Res       Date:  2011-01-17
View more
  9 in total

Review 1.  Stem cells and cell-based therapies for cerebral palsy: a call for rigor.

Authors:  Lauren L Jantzie; Joseph Scafidi; Shenandoah Robinson
Journal:  Pediatr Res       Date:  2017-11-01       Impact factor: 3.756

Review 2.  Progress in clinical trials of stem cell therapy for cerebral palsy.

Authors:  Zhong-Yue Lv; Ying Li; Jing Liu
Journal:  Neural Regen Res       Date:  2021-07       Impact factor: 5.135

3.  Multimodal imaging of hair follicle bulge-derived stem cells in a mouse model of traumatic brain injury.

Authors:  Timo Schomann; Juvita D Iljas; Ivo Que; Yuedan Li; Ernst Suidgeest; Luis J Cruz; Johan H M Frijns; Alan Chan; Clemens M W G Löwik; Margriet A Huisman; Laura Mezzanotte
Journal:  Cell Tissue Res       Date:  2020-02-08       Impact factor: 5.249

4.  Therapeutic evidence of umbilical cord-derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial.

Authors:  Jiaowei Gu; Li Huang; Che Zhang; Yong Wang; Ruibo Zhang; Ziliang Tu; Hengdong Wang; Xihui Zhou; Zhousheng Xiao; Zegan Liu; Xiang Hu; Zunchen Ke; Dabin Wang; Li Liu
Journal:  Stem Cell Res Ther       Date:  2020-02-03       Impact factor: 6.832

5.  The safety and efficacy of umbilical cord blood mononuclear cells in individuals with spastic cerebral palsy: a randomized double-blind sham-controlled clinical trial.

Authors:  Morteza Zarrabi; Masood Ghahvechi Akbari; Man Amanat; Anahita Majmaa; Ali Reza Moaiedi; Hadi Montazerlotfelahi; Masoumeh Nouri; Amir Ali Hamidieh; Reza Shervin Badv; Hossein Karimi; Ali Rabbani; Ali Mohebbi; Shahram Rahimi-Dehgolan; Rosa Rahimi; Ensieh Dehghan; Massoud Vosough; Saeed Abroun; Farhad Mahvelati Shamsabadi; Ali Reza Tavasoli; Houman Alizadeh; Neda Pak; Gholam Reza Zamani; Mahmoud Mohammadi; Mohsen Javadzadeh; Mohammad Ghofrani; Seyed Hossein Hassanpour; Morteza Heidari; Mohammad Mehdi Taghdiri; Mohamad Javad Mohseni; Zahra Noparast; Safdar Masoomi; Mehrdad Goudarzi; Masood Mohamadpour; Razieh Shodjaee; Solaleh Samimi; Monireh Mohammad; Mona Gholami; Nahid Vafaei; Leyli Koochakzadeh; Amir Valizadeh; Reza Azizi Malamiri; Mahmoud Reza Ashrafi
Journal:  BMC Neurol       Date:  2022-03-29       Impact factor: 2.474

6.  Multi-Hit White Matter Injury-Induced Cerebral Palsy Model Established by Perinatal Lipopolysaccharide Injection.

Authors:  Le Liu; Liwei Fang; Boyang Duan; Yue Wang; Zhenzhen Cui; Li Yang
Journal:  Front Pediatr       Date:  2022-06-06       Impact factor: 3.569

7.  Human neural stem cells dispersed in artificial ECM form cerebral organoids when grafted in vivo.

Authors:  Reem Basuodan; Anna P Basu; Gavin J Clowry
Journal:  J Anat       Date:  2018-05-10       Impact factor: 2.610

8.  A New Approach to Cerebral Palsy Treatment: Discussion of the Effective Components of Umbilical Cord Blood and its Mechanisms of Action.

Authors:  Yang Jiao; Xiao-Yan Li; Jing Liu
Journal:  Cell Transplant       Date:  2018-11-01       Impact factor: 4.064

Review 9.  Stem Cell Therapies for Cerebral Palsy and Autism Spectrum Disorder-A Systematic Review.

Authors:  Justyna Paprocka; Konrad Kaminiów; Sylwia Kozak; Karolina Sztuba; Ewa Emich-Widera
Journal:  Brain Sci       Date:  2021-12-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.